Exhibit 107
Calculation of Filing Fee Tables
S-3, 424(b)(7)
(Form Type)
Biohaven Pharmaceutical Holding Company Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
| Security Type | Security Class Title | Fee
Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee(2) | Carry Forward Form Type | Carry Forward File Number | Carry
Forward
Initial
Effective
Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward |
| Newly Registered Securities |
Fees to Be Paid | Equity | Common Shares, no par value | 456(b), 457(c), 457(r) | 493,254 | $150.74 (1) | $74,353,107.96 (1) | 0.0000927 | $6,892.53 | | | | |
Fees Previously Paid | | | | | | | | | | | | |
| Carry Forward Securities |
| | | | | | | | | | | | |
| Total Offering Amounts | | | | $74,353,107.96 | | | | |
| Total Fees Previously Paid | | | | | | | | |
| Total Fee Offsets | | | | | | | | |
| Net Fee Due | | | | $6,892.53 | | | | |
| | | | | |
| (1) | Estimated solely for purposes of calculating the registration fee in accordance with Rules 457(c) and 457(r) of the Securities Act of 1933, as amended (the “Securities Act”), and based upon the average of the high and low sales price of a share of the Registrant’s common shares, as reported by the New York Stock Exchange on September 12, 2022. |
| | | | | |
| (2) | Calculated in accordance with Rules 456(b), 457(c) and 457(r) of the Securities Act. |
